VALTREX

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, Hong Kong, Ireland, Israel, Japan, Lithuania, Nigeria, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States

Active ingredients

The drug VALTREX contains one active pharmaceutical ingredient (API):

1 Valaciclovir UNII G447S0T1VC - VALACYCLOVIR HYDROCHLORIDE

Valaciclovir, an antiviral, is the L-valine ester of aciclovir. Valaciclovir is rapidly and almost completely converted in man to aciclovir and valine. Aciclovir is a specific inhibitor of the herpes viruses with in vitro activity against herpes simplex viruses (HSV) type 1 and type 2, varicella zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr Virus (EBV), and human herpes virus 6 (HHV-6). Read about Valaciclovir

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VALTREX Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AB11	Valaciclovir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
Discover more medicines within J05AB11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5480K, 6280M, 8064K, 8133C, 8134D, 9568N
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510608401111314, 510608402116311
Country: CA	Health Products and Food Branch	Identifier(s): 02219492, 02246559
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 24.450-04-02
Country: EE	Ravimiamet	Identifier(s): 1016301, 1529513, 1539862, 1539873, 1539884, 1539895, 1680757, 1680768, 1680779, 1680780, 1680791, 1680803, 1831003
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61240, 61241
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 175612, 184598, 374397, 377333
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 106859, 146911, 147492, 21860, 21862, 398806, 398807
Country: HK	Department of Health Drug Office	Identifier(s): 49389
Country: IE	Health Products Regulatory Authority	Identifier(s): 51800, 51842, 51865, 58818
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3166, 3383
Country: JP	医薬品医療機器総合機構	Identifier(s): 6250019D1020, 6250019F1020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1002787, 1059619, 1059620, 1059621, 1059622, 1060083, 1068921, 1087919
Country: NG	Registered Drug Product Database	Identifier(s): 04-8114
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7349, 7350, 7351
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100081024
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65100001, W65100002, W65100003, W65100004, W65100005, W65100006
Country: SG	Health Sciences Authority	Identifier(s): 08229P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522092505, 8699522092512, 8699522097524
Country: US	FDA, National Drug Code	Identifier(s): 0173-0565, 0173-0933